Aytu BioScience Announces ZolpiMist Global Distribution Agreement with SUDA Pharmaceuticals, page-65

This is the announcement released about Magna the global owner of Zolpimist exclusively licensing Zolpimist to AYTU for USA and Canada - nothing about the rest of the world which Magna licensed Suda 

PERTH, AUSTRALIA – 15 June 2018: SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, today announced that Magna Pharmaceuticals, Inc., the globalowner of ZolpiMist (zolpidem tartrate oral spray), has exclusively licensed the product inthe USA and Canada to Englewood, Colorado-based, Aytu BioScience, Inc. (NASDAQ: AYTU).Aytu is an emerging specialty pharmaceutical company and will add ZolpiMist to its currentcommercial portfolio which includes a testosterone replacement nasal gel, Natesto